Recently, CFI has organized a Symposium, focusing on the key points of the Chinese TCM Conference and 2025 academic conference on TCM quality. The industry consensus centered on "quality first and innovation-driven", exploring the path to the modernization of TCM with products at its core. As an enterprise specializing in TCM, CFI always regards the products as the bridge between traditional wisdom and contemporary demands. 

Group executive has realized that in the context of the standardization of the traditional Chinese medicine industry and high-quality development, the products are the key levers for the company to connect with the market and create value. CFI has made it clear that it will be guided by the principle of the conference, strengthening the core position of product strategy in enterprise development. Through industry-university-research cooperation, CFI enhances the core technology of products. By accurately grasping market demands, we optimize the product structure. Through a complete quality control system throughout the process, we ensure the competitiveness of the products. We systematically improve the comprehensive performance of the products in terms of user experience and market adaptability, further strengthening the underlying support for the commercial value of the enterprise.

In the years ahead, CFI will take its products as an effective lever, through technology empowerment and in-depth quality cultivation, and let traditional Chinese medicine serve public health in a more reliable and efficient form, to offer strong support to enhance core competitiveness.